article thumbnail

Schedule III Marijuana Would Still Be Regulated Marijuana

FDA Law Blog: Biosimilars

Houck In August 2023, the U.S. In January a public hearing began to receive factual evidence and testimony on whether marijuana should be rescheduled. By Larry K. Department of Justice subsequently conducted a separate Eight Factor Analysis and concurred with HHS rescheduling recommendation.

article thumbnail

Respiratory Illnesses in China Not Caused by New Virus, CDC Director Testifies

Drugs.com

1, 2023 (Healthday News) -- In testimony provided Thursday to members of Congress, the head of the U.S. FRIDAY, Dec. Centers for Disease Control and Prevention said that a surge in respiratory illnesses in China is not being fueled by a new.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Analysis Life Sciences Thank You What We Expect the FDA to do in July 2023

Agency IQ

What We Expect the FDA to do in July 2023 In this ongoing feature, AgencyIQ looks at public data to determine what the FDA is likely to do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods and more. But could it be a busy month for rulemaking?

FDA 40
article thumbnail

GAO Report on Clinical Research Inspections Encourages FDA to Care for its Clinical Inspection Program

FDA Law Blog: Biosimilars

That report prompted a hearing on Capitol Hill in February of this year where HPM Counsel John Claud offered testimony. Complete numbers for 2023 and 2024 are not available, but it appears that FDA was only able to complete 537 BIMO inspections in 2022. The vast majority are for drugs.

article thumbnail

FDA Returns Disappointing News for ALS Stem Cell Therapy

PLOS: DNA Science

But it took until this September 27, 2023, for FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee to finally vote. The amazing testimonials we have seen online do not align with the data that BrainStorm has shared with us or has been published in peer-reviewed publications.

Therapies 101
article thumbnail

Analysis Chemical Thank You Cities are dropping out of a major PFAS settlement. What are the ramifications?

Agency IQ

BY WALKER LIVINGSTON, ESQ | NOV 29, 2023 6:48 PM EST AFFF suit and proposed settlements Beginning in 2019, the U.S. The case proceeded, and reached its first major settlement in early June 2023, when DuPont, Corteva, and Chemours reached an agreement to settle all claims for a combined $1.185 billion settlement.

article thumbnail

New Years Resolutions Medical Device Marketers Should Make in 2024 

Perficient: Drug Development

I mean, it was Merriam Webster’s word of the year in 2023.) One way is to lean into consumer quotes and testimonials, whether patients or clinical profiles. However, consumers have made it clear that authenticity is exactly what they are after. (I So how can you strike the balance?